Emerging Ethical Challenges in Living Kidney Donation
Purpose of Review
Living-donor kidney transplantation (LDKT) offers the best medical outcomes in terms of graft and patient survival for end-stage renal disease (ESRD) patients. LDKT involves a medically and psychologically suitable individual willingly agreeing to donate a kidney to a loved one or stranger. It is a unique situation in which a healthy person consents to having a medical procedure for another person’s benefit. LDKT raises numerous ethical issues, particularly with respect to voluntary consent, risks and benefits, and vulnerability.
In recent years, the discovery of APOL1, a gene associated with increased risk of chronic kidney disease and ESRD in African Americans, and unique situations arising from requests to undergo living donation from persons who are not traditionally healthy or have social circumstances that may challenge influence-free, informed decision making have challenged the ethics of LDKT.
In this article, we discuss the ethical issues surrounding three emerging situations in LDKT: living kidney donors with life-limiting illness, incarcerated living kidney donors, and APOL1 genotyping in the context of living donor candidate evaluation.
KeywordsLiving kidney donation Bioethics Living donors with life-limiting illness Inmates as living donors APOL1 genetic testing Informed consent
Dr. Fortin is a research scholar of the Fonds de recherche du Québec–Santé (career award).
Compliance with Ethical Standards
Conflict of Interest
Virginie Vallée Guignard and Marie-Chantal Fortin declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 3.Rabaux Y. Étude sur l’économique de l’insuffisance rénale. La Fondation canadienne du rein - Division Québec, 2012 November 12. Report No.Google Scholar
- 10.Mezrich JD, Scalea J. As they lay dying. The Atlantic. 2015;2015.Google Scholar
- 11.Cook R. Cherokee man with ALS wants to die by donating organs: the Atlanta journal constitution; 2010 [cited 2019 January 10]. Available from: https://www.ajc.com/news/local/cherokee-man-with-als-wants-die-donating-organs/m54v91KOBL833r4toGTSQI/.
- 12.Shakerdge K. A dying Man's wish to donate his organs gets complicated: National Public Radio; 2016 [updated December 26; cited 2019 January 10]. Available from: https://www.npr.org/sections/health-shots/2016/12/26/499494248/a-dying-man-s-wish-to-donate-his-organs-gets-complicated.
- 13.• Rakke YS, Zuidema WC, Hilhorst MT, Erdman RA, Massey EK, Betjes MG, et al. Seriously ill patients as living unspecified kidney donors: rationale and justification. Transplantation. 2015;99(1):232–5 This is an important article because it is the first to describe living kidney donation by patients with life-limiting illness. CrossRefGoogle Scholar
- 14.• Troppmann C, Santhanakrishnan C, Sageshima J, McVicar J, Perez R. Barriers to live and deceased kidney donation by patients with chronic neurological diseases: implications for donor selection, donation timing, logistics, and regulatory compliance. Am J Transplant. 2018; This is an important article because it reports the experience of deceased and living organ donation by patients with neurological life-limiting illness in the United States. Google Scholar
- 15.• Ansari S, Bromberg MB, Gibson SB. Physician perceptions about living organ donation in patients with Amyotrophic Lateral Sclerosis. Clin Neurol Neurosurg. 2017;160:125–9 This is an important article because it provides empirical data on neurologists' perspectives about organ donation by patients with ALS. CrossRefGoogle Scholar
- 16.Kipnis K. Vulnerability in research subjects: a bioethical taxonomy. National Bioethics Advisory Commission [NBAC] ethical and policy issues in research involving human participants 2001;Volume II: Commissioned Papers, 2004.Google Scholar
- 17.•• OPTN/UNOS Ethics Committee. Living Organ Donation by Persons with Certain Fatal Diseases. 2017. This report provides ethical guidelines for living organ donation by persons with life-limiting illness. Google Scholar
- 19.Williams T. Jailed Sisters are Released for Kidney Transplant: The New York Times; 2011 [cited 2019 January 15]. Available from: https://www.nytimes.com/2011/01/08/us/08sisters.html.
- 20.James SD. Scott Sisteres kidney donation threatens organ transplant Laws: ABC news; 2010 [cited 2019 January 15]. Available from: https://abcnews.go.com/Health/scott-sisters-kidney-donation-threatens-organ-transplant-laws/story?id=12515616.
- 23.Ross S. With organ donation, Let Prisoners Give Life to Others: The New York Times; 2013 [cited 2019 January 17]. Available from: https://www.nytimes.com/roomfordebate/2013/04/25/should-prisoners-be-allowed-to-donate-their-organs/with-organ-donations-let-prisoners-give-life-to-others.
- 24.US Department of Justice. Program Statement, Patient Care: Federal Bureau of Prisons,; 2014 [cited 2019 January 17]. Available from: https://www.bop.gov/policy/progstat/6031_004.pdf.
- 26.Gates ML, Turney A, Ferguson E, Walker V, Staples-Horne M. Associations among substance use, mental health disorders, and self-harm in a prison population: examining group risk for suicide attempt. Int J Environ Res Public Health. 2017;14(3).Google Scholar
- 29.Federal Bureau of Prisons. Inmate Race: US Government, Departement of Justice; 2018 [updated November 24; cited 2019 January 16]. Available from: https://www.bop.gov/about/statistics/statistics_inmate_race.jsp.
- 30.Guidance on the use of increased infectious risk donors for organ transplantation. Transplantation. 2014;98(4):365–9.Google Scholar
- 37.Lentine K, Kasiske B, Levey A, Adams P, Alberú J, Bakr M, et al. KDIGO clinical practice guideline on the evaluation and Care of Living Kidney Donors. Transplantation. 2017;101(8S Suppl 1):S1–S109.Google Scholar
- 38.British Transplantation Society. Guidelines for Living Donor Kidney Transplantation 2018 [cited 2019 January 16]. Available from: https://bts.org.uk/wp-content/uploads/2018/07/FINAL_LDKT-guidelines_June-2018.pdf.
- 39.• Gordon EJ, Amomicronrtegui D, Blancas I, Wicklund C, Friedewald J, Sharp RR. African American living Donors' attitudes about APOL1 genetic testing: a mixed methods study. Am J Kidney Dis. 2018;72(6):819–33 This is an important paper describing AA living donors' attitudes about APOL1 genetic testing. CrossRefGoogle Scholar
- 40.• Gordon EJ, Wicklund C, Lee J, Sharp RR, Friedewald J. A national survey of transplant surgeons and nephrologists on implementing Apolipoprotein L1 ( APOL1) genetic testing into clinical practice. Prog Transplant. 2018:1526924818817048 This is an important article describing physicians' practices and perspectives on APOL1 testing in living kidney donation. Google Scholar
- 42.•• Ross LF, Thistlethwaite JR Jr. Introducing genetic tests with uncertain implications in living donor kidney transplantation: ApoL1 as a case study. Prog Transplant. 2016;26(3):203–6 This is a very interesting article which provides an ethical analysis of different options for APOL1 genetic testing in living donor kidney transplantation. CrossRefGoogle Scholar
- 43.Edwards A, Elwyn G. Shared decision-making in health care: achieving evidence-based patient choice. Oxford: Oxford University Press; 2009. 414 pGoogle Scholar